Country: Ireland
Bahasa: Inggeris
Sumber: HPRA (Health Products Regulatory Authority)
IRINOTECAN HYDROCHLORIDE TRIHYDRATE
Flynn Pharma Ltd
IRINOTECAN HYDROCHLORIDE TRIHYDRATE
20 Micromol
Concentrate for Soln for Inf
Product subject to prescription which may not be renewed (A)
Withdrawn
2013-12-09
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA1226/007/001 Case No: 2070065 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to FLYNN PHARMA LTD ALTON HOUSE, 4 HERBERT STREET, DUBLIN 2, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product IRINOTECAN HYDROCHLORIDE TRIHYDRATE 20 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 09/06/2010 until 30/07/2014. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 09/06/2010_ _CRN 2070065_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Irinotecan hydrochloride trihydrate 20 mg/ml concentrate for solution for infusion. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The solution contains 20 mg/ml irinotecan hydrochloride trihydrate (equivalent to 17.33 mg/ml irinotecan). Each 2 ml vial contains 40 mg irinotecan hydrochloride trihydrate. Each 5 ml vial contains 100 mg irinotecan hydrochloride trihydrate. Excipients: Sorbitol E420 Sodium For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Concentrate for solution for infusion Clear, yellow solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDI Baca dokumen lengkap